Cambridge Healthtech Institute’s 28th Annual
Display of Biologics
Imagining the Next Generation of Biologics
May 11-12, 2026
Phage, yeast, and mammalian displays have been instrumental for generating therapeutic molecules against a wide range of diseases. Cambridge Healthtech Institute's 28th annual Display of Biologics conference is the cornerstone of PEGS Boston and brings together leaders to showcase emerging technologies and approaches that are creating novel formats and functionalities. Understanding the role of machine learning and AI to build and navigate repertoires and libraries is at the forefront of the field and accelerating the pace of discovery.
Coverage will include, but is not limited to:
- Discovering and designing new biologics including peptides and mini-proteins with emerging platforms
- Selecting, optimizing, and developing biologics including novel formats with display
- Tackling challenging targets with phage, yeast, and mammalian display
- Employing novel platforms and alternative scaffolds for radio- and chemotherapy applications
- Using AI/ML to design and improve antibodies
- Expanding precision-activated approaches
- Expanding repertoires with machine-learning-assisted directed-evolution techniques to improve outcomes
The deadline for priority consideration is October 31, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: